Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 560,633 | 572,619 | 553,979 | 616,847 | 545,138 |
| Cost of Goods | 253,607 | 264,850 | 242,217 | 284,282 | 258,422 |
| Gross Profit | 307,026 | 307,769 | 311,762 | 332,565 | 286,716 |
| Operating Expenses | 250,173 | 252,229 | 255,373 | 559,901 | 250,863 |
| Operating Income | 57,460 | 56,390 | 56,606 | -227,054 | 36,275 |
| Interest Expense | 5,525 | 5,841 | 5,986 | 6,139 | 6,064 |
| Other Income | -387,151 | 719,052 | 1,076,646 | -808,054 | 319,920 |
| Pre-tax Income | -335,216 | 769,601 | 1,127,266 | -1,041,247 | 350,131 |
| Income Tax | -76,400 | 170,791 | 262,071 | -212,718 | 80,805 |
| Net Income Continuous | -258,816 | 598,810 | 865,195 | -828,529 | 269,326 |
| Net Income | $-258,816 | $598,810 | $865,195 | $-828,529 | $269,326 |
| EPS Basic Total Ops | -8.68 | 20.08 | 29.03 | -27.81 | 9.02 |
| EPS Basic Continuous Ops | -8.68 | 20.08 | 29.03 | -27.80 | 9.02 |
| EPS Diluted Total Ops | -8.68 | 19.86 | 28.74 | -27.43 | 8.89 |
| EPS Diluted Continuous Ops | -8.68 | 19.86 | 28.74 | -27.43 | 8.89 |
| EBITDA(a) | $57,460 | $56,390 | $56,606 | $-227,054 | $71,175 |